GE Gets FDA Approval for Mobile X-Ray Systems
GE Healthcare has received FDA clearance of its Optima XR220amx, Optima XR200amx and Brivo XR285amx, a new platform of mobile x-ray systems.
GE Healthcare has received FDA clearance of its Optima XR220amx, Optima XR200amx and Brivo XR285amx, a new platform of mobile x-ray systems.
The product line responds to aging populations, rising obesity rates, and an increasing demand for patient-centric medical care by creating a “radiology room on wheels.”
The machines provide fast, low-dose images for diagnoses in challenging clinical settings.
The digital Optima XR220amx, digital-ready Optima XR200amx and Brivo XR285amx, are more compact and powerful than earlier models, featuring intuitive touch screens, immediate start-up capability, more storage and the high image quality required today.
The Optima XR220amx also immediately integrates with GE’s FlashPad digital wireless detector.
Can Contrast-Enhanced Mammography be a Viable Screening Alternative to Breast MRI?
June 17th 2025While the addition of contrast-enhanced mammography (CEM) to digital breast tomosynthesis (DBT) led to over a 13 percent increase in false positive cases, researchers also noted over double the cancer yield per 1,000 women in comparison to DBT alone.
Multinational Study Reaffirms Value of Adjunctive AI for Prostate MRI
June 16th 2025The use of adjunctive AI in biparametric prostate MRI exams led to 3.3 percent and 3.4 percent increases in the AUC and specificity, respectively, for clinically significant prostate cancer (csPCa) in a 360-person cohort drawn from 53 facilities.
Contrast-Enhanced Mammography and High-Concentration ICM Dosing: What a New Study Reveals
June 16th 2025New research showed a 96 to 97 percent sensitivity for contrast-enhanced mammography (CEM) with an increased iodine delivery rate facilitating robust contrast enhancement for women with aggressive breast cancer.
